HomepageMedicineFDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors Medicine FDA Approves Roche’s Cobas Malaria Test, Designed to Screen for Malaria in Potential Blood Donors admin Posted on March 28, 2024 Action marks the first FDA-approved blood screening test for malaria. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostSquamous Cell Carcinoma in Cats: Causes, Signs & Treatments (Vet Answer) Next PostHas the Luxury E-Commerce Bubble Burst? You Might Also Like Medicine FDA Approves Fresenius Kabi, Formycon’s Stelara Biosimilar for Multiple Inflammatory Diseases admin October 3, 2024 Medicine FDA Approves Roche’s Itovebi for Endocrine-Resistant, PIK3CA-Mutated Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer admin October 12, 2024 Medicine NVIDIA Announces Pharma Partnerships to Expand AI admin January 15, 2025 Medicine Addressing Unmet Needs with LP-284 for Relapsed/Refractory Lymphomas and Solid Tumors admin May 12, 2024
Medicine FDA Approves Fresenius Kabi, Formycon’s Stelara Biosimilar for Multiple Inflammatory Diseases admin October 3, 2024
Medicine FDA Approves Roche’s Itovebi for Endocrine-Resistant, PIK3CA-Mutated Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer admin October 12, 2024
Medicine Addressing Unmet Needs with LP-284 for Relapsed/Refractory Lymphomas and Solid Tumors admin May 12, 2024